SilverBox Corp IV (NYSE:SBXD) and OSR (NASDAQ:OSRH) Head to Head Contrast

SilverBox Corp IV (NYSE:SBXD) and OSR (NASDAQ:OSRH) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Profitability

This table compares SilverBox Corp IV and OSR’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SilverBox Corp IV	N/A	N/A	N/A
OSR	N/A	-6.66%	-4.90%

Insider & Institutional Ownership

55.3% of OSR shares are owned by institutional investors. 60.6% of OSR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and price targets for SilverBox Corp IV and OSR, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SilverBox Corp IV	1	0	0	0	1.00
OSR	1	0	0	0	1.00

Earnings and Valuation

This table compares SilverBox Corp IV and OSR”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SilverBox Corp IV	N/A	N/A	$3.48 million	$0.17	62.44
OSR	N/A	N/A	-$2.41 million	($1.12)	-0.62

OSR is trading at a lower price-to-earnings ratio than SilverBox Corp IV, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

SilverBox Corp IV has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500. Comparatively, OSR has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500.

Summary

SilverBox Corp IV beats OSR on 5 of the 8 factors compared between the two stocks.

About SilverBox Corp IV

Silverbox Corp. IV is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 16, 2024 and is headquartered in Austin, TX.

About OSR

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.